Background/Purpose: The clinical aspects of virulence genes of uropathogenic Escherichia coli (UPEC) are not fully understood. This study compared the presence of virulence genes in UPEC isolated from urinary tract infections (UTIs) and asymptomatic bacteriuria (ABU) in children.
Introduction
Urinary tract infection (UTI) refers to an infection with microbial pathogens at any site in the urinary tract, which includes the urethra, bladder, ureter, and kidneys. UTI is the most common bacterial infection in children; many affected children, particularly infants, have severe symptoms and lobar nephronia. Kidney scarring related to UTI has been linked to long-term morbidity. 1, 2 By contrast, asymptomatic bacteriuria (ABU) is a condition in which bacteria subclinically colonize the urinary tract, closely resembling commensalism at other mucosal sites. ABU strains are well adapted for growth in the human urinary tract, without causing any clinical symptoms. Therefore, ABU strains are an interesting model for the study of mechanisms of commensalism and the driving forces between the pathogen and the host. 3, 4 Uropathogenic Escherichia coli (UPEC) are the most common bacterial pathogens that cause UTI and ABU in children. Extended-spectrum beta-lactamases-producing UPEC strains, which are increasing in prevalence worldwide, have an appreciable deleterious impact on the clinical management of UTI. 5, 6 The UPEC strains harbor many genes that encode various virulence factors, which contribute to enhanced pathogenicity. The molecular characteristics and functions of these virulence genes have been well established. 7e12 The severity of UTI reflects the virulence profile or phenotype of the infecting strain, with many virulence factors being expressed fully at a higher frequency by strains causing UTI than by strains causing ABU. 13e15 In this study, we sought to identify the prevalence and expression patterns of virulence genes in UPEC isolated from children in South Korea. We also compared the virulence gene repertoire in UPEC strains isolated from UTIs and ABU, with the aim of clarifying important virulence factors for the development of clinical diseases of the urinary tract in children.
Materials and methods

Participants
This study was performed at Chung-Ang University Yongsan Hospital between March 2010 and February 2011. All participants were children <18 years of age who lived in Seoul, Korea, during the study period. Inclusion criteria were fever with an axillary temperature of !38 C, positive urine culture (>10 5 colony-forming units/mL), and pyuria (>5 white blood cells/high-power field). Children who did not have any urinary symptoms (i.e., urgency, frequency, and dysuria) but had significant growth of E. coli (>10 5 colony-forming units/mL) were considered to have ABU. The urine samples were collected through midstream urine in toilet-trained children and by a sterile urine-collecting bag in others. The study protocol was reviewed and approved by the Institutional Review Board (No. 10-013-02-03) at Chung-Ang University Hospital, and written informed consent was obtained from the parents/guardians of all participants.
Detection of virulence genes
All E. coli isolates were identified by typical morphology, lactose fermentation, positive spot indole test, and VITEK 2-GN card (bioMérieux, Hazelwood, MO, USA). Only one isolate per patient was examined. Extraction and purification of DNA from all UPEC isolates were performed as described in the QIAamp Kit (Qiagen GmbH, Hilden, Germany). The presence of the following virulence genes was assessed by 18 simplex polymerase chain reaction (PCR):adhesion proteins (papA, papC, papEF, papGI, papGII, papGIII, sfa, fimH, afa, bmaE ), toxins (hlyA, cdtB), siderophores (fyuA, iutA, feoB), capsule synthesis proteins (kpsMTII, kpsMTIII ), and uropathogenic-specific protein (usp). Primer sequences for amplification of these individual virulence genes have been published in previous studies 16e19 and are listed in Table 1 . PCR was consistently performed in a 20-mL reaction volume, with each reaction mixture containing 1.0 mL of DNA template, 10 mM of each primer, 2.0 mL of 10Â Taq buffer, 2.5 mM of deoxynucleotide triphosphates, and 2.5 mM of Taq polymerase (iNtRON, Seoul, Korea). Thermal cycling was performed in a PTC-200 Peltier thermal cycler DNA engine (MJ Research, Watertown, MA, USA) under the following conditions: denaturation for 5 minutes at 94 C; 35 1-minute amplification cycles at 94 C, and additional amplification cycles for 1 minute at 55 C, 2 minutes at 72 C, and a final extension cycle for 10 minutes at 72 C. The PCR products were electrophoresed on agarose gels, stained with ethidium bromide, and photographed using a UV transillumination imaging system.
Antimicrobial susceptibility test
Antimicrobial susceptibility testing of all isolates to ampicillin, gentamicin, piperacillin, trimethoprim/sulfamethoxazole, tetracycline, amoxicillin/clavulanic acid, cefazolin, aztreonam, ciprofloxacin, cefepime, cefotaxime, tobramycin, piperacillin/tazobactam, and levofloxacin was performed using the VITEK 2 automated system (bioMérieux). In addition, in vitro antimicrobial susceptibility testing was performed by the broth microdilution method and the results were interpreted using the 2010 Clinical and Laboratory Standards Institute breakpoints.
Statistical analyses
All statistical analyses were performed using SPSS version 18.0 (SPSS, Chicago, IL, USA). The prevalence of virulence genes and antibiotic resistance patterns were compared between the two groups using Pearson Chi-square test and Fisher exact test. Continuous variables were compared with the Student t test and ManneWhitney U test. A p value <0.05 was considered statistically significant.
Results
Clinical characteristics
A total of 64 patients were included in this study, of which 15 were diagnosed with UTI and 49 with ABU. In patients with ABU, 21 were healthy children and 28 were children with other diseases; upper respiratory tract infection (n Z 9), bronchiolitis (n Z 8), functional gastrointestinal disorder (n Z 5), and acute gastroenteritis (n Z 6). Each UTI and ABU group contained both outpatients and inpatients. The median age was 7.5 months (range: 1.6e98.8 months) in the UTI group and 15.4 months (range: 0.5e167.9 months) in the ABU group ( Table 2 ). The ratio of males to females was 2:1 in the UTI group and 1.7:1 in the ABU group. There were no statistically significant differences in age and sex of participants (p >0.05, respectively). By contrast, higher levels of Creactive protein, increased erythrocyte sedimentation rate, and a proportion of neutrophil were identified among patients diagnosed with UTI (p <0.05, for all).
Virulence gene repertoire in UPEC
Eighteen virulence genes were explored to determine the virulence repertoire in the UPEC isolates. The frequently identified virulence genes were fimH (n Z 62, 96.9%), kpsMTII (n Z 54, 84.4%), feoB (n Z 43, 67.2%), iutA (n Z 34, 53.1%), fyuA (n Z 29, 45.3%), and papA (n Z 29, 45.3%). The papGI, cdtB, and kpsMTIII genes were not detected ( Table 3) . Isolates from the ABU group expressed fewer virulence factors than those from the UTI group (4.98 AE 1.81 vs. 5.93 AE 1.44, respectively, p < 0.05, data not shown). The prevalence of virulence genes in patients over 6 months of age did not differ from those in patients <6 months of age (p >0.05, data not shown). The components of the virulence genes were similar in both sexes, except for papEF, which was found more frequently in females than in males (p <0.05, data not shown).
In patients with UTI and ABU, the virulence gene most frequently detected was fimH (UTI group: n Z 15, 100.0%; ABU group: n Z 47, 95.9%). In the UTI group, kpsMTII (n Z 14, 93.3%), fyuA (n Z 12, 80.0%), iutA (n Z 9, 60.0%), and papA (n Z 9, 60.0%) were commonly identified in that order. The detected genes in the ABU group, in descending order of prevalence, were feoB (n Z 40, 81.6%), kpsMTII (n Z 40, 81.6%), iutA (n Z 25, 51.0%), and papA (n Z 20, 40.8%). Only three virulence genes showed a meaningful difference of distribution between the groups; UTI isolates showed a higher prevalence of papEF and fyuA, and a lower prevalence of feoB than ABU isolates (p <0.01 for all, Table  3 ). There were no significant differences in the number of detected virulence genes according to sex and age group (<6 months vs. !6 months of age) in the UTI and ABU groups (data not shown).
Prevalence of the specific profiles of virulence genes was analyzed. On the basis of fimH and kpsMTII, we considered the combinations of three common virulence genes, namely, iutA, feoB, and papA. The virulence profiles fimH þ kpsMTII þ iutA þ and fimH þ kpsMTII þ papA þ (n Z 8, 53.3%, in both) were most common in the UTI group and fimH þ kpsMTII þ feoB þ (n Z 33, 67.3%) was most common in the ABU group. There was a significant difference between the two groups concerning the prevalence of the fimH þ kpsMTII þ feoB þ profile (20.0% in the UTI group vs. 67.3% in the ABU group; p <0.01, Table 3 ).
Antimicrobial susceptibility
Antimicrobial susceptibility patterns were different according to the origin of UPEC. Isolates from ABU were more resistant to all tested antimicrobials, except cefazolin and tetracycline. Among them isolates of ABU were significantly more resistant to piperacillin and cefotaxime than UTI (67% vs. 27%; 100% vs. 74%, p <0.05, respectively, Table 4 ). However, there were no significant differences in antimicrobial susceptibility according to sex and age group (<6 months vs. !6 months of age) in the UTI and ABU groups (data not shown). By contrast, there was no relationship between the presence of virulence genes and antimicrobial susceptibility of UPEC, except for papEF, feoB, and fyuA. The papEF and fyuA genes were more prevalent in tetracyclineresistant isolates than tetracycline-susceptible isolates (60% vs. 14%; 100% vs. 41%, p <0.05, respectively, Fig. 1A ). However, feoB was exclusively identified in tetracyclineand cefazolin-susceptible isolates, and was more frequently identified in cefotaxime-resistant isolates than susceptible isolates (92% vs. 61%, p <0.05, Fig. 1B) .
Discussion
ABU is a condition closely resembling bacterial commensalism at the mucosa of urinary tract, but is also considered as the most common form or risk factor of symptomatic UTI. 3,20e22 A recent study revealed that ABU might protect against symptomatic recurrence of UTI in young women. 23 The UPEC strains causing ABU may outcompete strains causing UTI in the urinary tract of humans. 24 These characteristics of ABU differentiate the virulence of the bacterial strains causing ABU from those causing UTI. The ABU strains reportedly express fewer virulence factors or harbor attenuated virulence genes than strains causing symptomatic UTI. 13e15 However, these studies were mostly performed in adults rather than in children, particularly infants, having more severe symptoms and complications. In the present study, we reported that ABU strains also expressed fewer virulence factors than UTI strains in children.
Virulence factors of UPEC are associated with colonization and survival in the normal urinary tract, and influence the pathogenicity of symptomatic or complicated UTIs. 9,25e27 These virulence factors are adhesion proteins (e.g., P fimbriae, S and F1C fimbriae, and type 1 fimbriae), iron-acquisition systems (e.g., aerobactin), toxins (e.g., hemolysin), and host defense-avoidance mechanisms (e.g., capsule or O-specific antigen). 28 Bacterial adherence to urinary epithelia is a crucial step in the development of UTI, allowing the bacteria to persist in the urinary tract against flushing by urine flow and activation of host signaling pathways. 11, 29 In mammalian hosts, free iron concentrations are very low for the growth of pathogenic bacteria. Thus, many bacteria, including UPEC, have multiple ways of getting iron from the host through the expression of iron-acquisition systems. 30 The utilization of various toxins secreted by UPEC strains is well recognized. Among these toxins, a-hemolysin encoded by hlyA is an extracellular cytolytic protein toxin that is produced by up to 50% of UPEC isolates. a-Hemolysin has been associated with clinical severity in UTI patients. 31 In our study, hlyA was detected in 20.0% of UTI strains and in 20.4% of ABU strains.
In this study, the fimH adhesion gene was the most common virulence gene in both UTI and ABU isolates (frequencies of 100% and 96%, respectively). Previous studies have established that fimH is most frequent in isolates from a variety of forms of UTI. 15,32e34 The pap gene family of adherence virulence genes (papA, papC, papEF, papGII, and papGIII in this study), which are expressed as P fimbriae, was also prevalent in the UTI and ABU isolates. Among the pap genes, papA was the second most prevalent adhesion gene in the UTI group (60.0%, n Z 9) and ABU group (40.8%, n Z 49). Furthermore, papEF was more frequently identified in the UTI group than in the ABU group (46.7% vs. 8.2%, respectively, p < 0.05). In some UPEC strains, it is conceivable that papEF is active in the progression to symptomatic UTI from ABU. One study described the presence of papEF in over half of the isolates obtained from severe invasive urinary tract diseases. 33 The third most common gene in the UTI isolates was fyuA (n Z 12, 80.0%), which is one of the bacterial ironacquisition systems. However, ABU isolates showed a much lower prevalence of fyuA (n Z 17, 34.7%, p <0.01). The finding supports the importance of fyuA in virulence, particularly in the establishment of symptomatic UTI. The relationship between fyuA and invasive UTI had been suspected in previous studies. 16, 18, 33 By contrast, a recent study reported that feoB and fimH were the most prevalent virulence genes of UPEC isolated from patients with community-acquired UTI in China. 34 In the present study, the prevalence of feoB in UTI isolates was much lower (20.0%) than those (>92%) reported in China. By contrast, feoB was identified in ABU strains at a higher frequency (81.6%) in our isolates. These discrepancies might be due to the difference in epidemiology of strains or lower UTI sample size in this study. The feoB gene might have a role in iron acquisition in both UTI and ABU, although it is unclear whether feoB works differently or has an additional individual mechanism in UTI or ABU strains.
Virulence factors may have distinctive and complex associations with one another. 16 To identify these associations and the phenotypes of the present isolates, the prevalence of profiles of the virulence genes was ascertained. The fimH þ kpsMTII þ feoB þ profile was significantly more prevalent in the ABU group (p < 0.01). This finding might be due to a much larger discrepancy of feoB prevalence than fimH and kpsMTII between the two groups. In addition, it could be possible that fimH and kpsMTII make the UPEC strain more suitable for commensalism in the human urinary tract when expressed with feoB.
Patients with UTI need early diagnosis and prompt antibacterial treatment to minimize renal scarring and progressive kidney damage. Empirical antibiotic treatment is usually started in patients with suspected UTI. However, antibiotic resistance has increased and is currently a major problem in many countries. 6, 28 In this study, isolates from ABU were found to be more resistant to most antimicrobials tested, as shown in a previous study. 15 It might be that longterm exposure to various antimicrobials for ABU strains induced antimicrobial resistances. By contrast, several studies reported the relationship between antimicrobial resistance and virulence factors of UPEC. Nalidixic acid resistance has been associated with a lower prevalence of sfa and a lower prevalence of pap, hly, and cnf1 has been reported in fluoroquinolone-resistant strains than their susceptible counterparts. 35, 36 Another study described that all pap elements except for papG allele III, sfa/foc, kpsMTII, fyuA, and hlyA were associated with decreased antibiotic resistance. 16 In this study, tetracycline-resistant strains more often harbored papEF and fyuA (p <0.05) and feoB was associated with increased cefotaxime resistance and tetracycline susceptibility (p <0.05). The presence and prevalence of virulence genes might depend on the antibiotic's mode of action or an unknown interaction between virulence factors and antibiotics.
This study had several limitations. One was a relatively small sample size, which requires further confirmation of the findings. In addition, there was a possibility of contamination of the urine samples derived from a urine bag. Nevertheless, the possibility of selection bias might be low because the inclusion criteria were strictly applied to all participants. Finally, we could not match the UTI and ABU groups for other conditions, such as host immunity, socioeconomic status, and history of antibiotic use. Despite these limitations, our study could be valuable for understanding molecular characteristics of UPEC, especially strains isolated from Korean children. The findings support the importance of some identified virulence genes as important effectors in the development of symptomatic UTI.
In conclusion, UPEC strains from Korean children with UTI and ABU had different molecular epidemiologic features concerning their major virulence genes. The papEF and fyuA genes were implicated as important virulence genes for development of UTI in children. Further investigations about feoB are needed to understand its significance in UTI or ABU.
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